Meningococcal group B vaccine receives Philippine FDA approval
The Philippine Food and Drug Administration (FDA) approved on October 15 the Meningococcal Group B Vaccine of GlaxoSmithKline (GSK) Philippines, a global biopharma company. The vaccine is for the prevention of meningococcal disease caused by the Neisseria meningitidis serogroup B in individuals aged two months or older. Prior this FDA approval, there was no vaccine […]
Tomas Kauer - News Moderator 
The Philippine Food and Drug Administration (FDA) approved on October 15 the Meningococcal Group B Vaccine of GlaxoSmithKline (GSK) Philippines, a global biopharma company. The vaccine is for the prevention of meningococcal disease caused by the Neisseria meningitidis serogroup B in individuals aged two months or older. Prior this FDA approval, there was no vaccine […]
